Methylene blue and light treatment
ProcedureMethylene blue and light treatment for 17 minutes are done twice over 1 week intervals.
NCT Number: NCT01981460
We are evaluating the effect of methylene blue and visible light activation on the microbiome of the skin.
Looking for future studies?
Notify Me21 year–60 year
All sexes
Interventional
Not applicable
Antiseptics are routinely utilized to prevent infections of vascular catheters. We are evaluating the addition of methylene blue and light activation on skin to determine whether this inexpensive and non-toxic treatment can decrease skin pathogens and prevent blood stream infections of long-term vascular catheters. This is a pilot study of normal volunteers to determine the effect on the microbiome of the addition of methylene blue and light activation on antiseptic-treated skin.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Methylene blue and light treatment for 17 minutes are done twice over 1 week intervals.
Time frame: 1 week
We compared the two arms of each subject --one arm treated with chloraprep and a biopatch [routine treatment of skin] to the routine treatment with the addition of methylene blue spray and light activation. The microbiome of both skin areas were assessed before and after the routine treatment and the treatment with the addition of methylene blue therapy;
Massachusetts General Hospital
Other
PhotoDynamic Therapy for Line Infection Prevention (PLIP): Pilot Study on Normal Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04155619
Behavior, Diabetes Mellitus
Birmingham, Alabama, United States
View Trial DetailsNCT03363529
Behavior, Behavioral Symptoms
Copenhagen, Denmark
View Trial DetailsNCT05009693
Cancer-related Fatigue, Light; Therapy, Complications
Eskişehir, Turkey (Türkiye)
View Trial DetailsNCT06731881
Infections, Light; Therapy, Complications
London, United Kingdom
View Trial Details